HBV mutation literature information.


  Hepatitis B Virus Genotypes and Antiviral Resistance Mutations in Romanian HIV-HBV Co-Infected Patients.
 PMID: 35454370       2022       Medicina (Kaunas, Lithuania)
Discussion: In our study, despite the frequent association of the primary resistance mutations M204V/I with the compensatory L180M, V173L, and L80V/I mutations, lamivudine-resistant HBV strains tend to be associated with lower viral loads compared to wild-type strains; further characterization of the viral strains, using Next-Generation Sequencing (NGS), might reveal the presence of other mutations that alter viral replication.
Discussion: The most frequently LAM-associated mutations detected in this study were M204V and V173L, commonly reported worldwide across all genotypes, with a similar distribution in HBV genotype A and D infections, as dual (M204V + L180M) and triple mutations (


  Hepatitis B virus genetic multiplicity and the associated HBV lamivudine resistance mutations in HBV/HIV co-infection in Western Kenya: A review article.
 PMID: 34954390       2022       Infection, genetics and evolution
Abstract: HBV polymerase rtV173L, rtL180M, and rtM204V major substitutional mutations were identified.


  Dried blood spot sampling for hepatitis B virus quantification, sequencing and mutation detection.
 PMID: 35102169       2022       Scientific reports
Abstract: An HIV-coinfected patient presented the rtM204V/I-rtL180M double resistance mutation in serum and DBS.
Result: One patient had the double resistance polymerase mutation rtM204V/I-rtL180M, in both serum and DBS.
Table: L180M


  Identification and Characterization of Besifovir-Resistant Hepatitis B Virus Isolated from a Chronic Hepatitis B Patient.
 PMID: 35203489       2022       Biomedicines
Discussion: But it may become a dominant species when combined with rtL180M mutation in vivo because of enhanced replication capability.
Discussion: On the other hand, rtL180M itself seems to be resistant to BFV as shown in Figure 3c, but there was stronger resistance to BFV in MV clone containing Discussion: The rtL180M and rtM204V mutations may have been occurred gradually while taking ETV as the first line anti-HBV agent.


  Reactivation of Occult Hepatitis B Virus Infection During Long-Term Entecavir Antiviral Therapy.
 PMID: 35359734       2022       Frontiers in microbiology
Table: L180M


  Recombinant HBsAg of the Wild-Type and the G145R Escape Mutant, included in the New Multivalent Vaccine against Hepatitis B Virus, Dramatically Differ in their Effects on Leukocytes from Healthy Donors In Vitro.
 PMID: 35214692       2022       Vaccines
Introduction: In contrast, the HBV variant with three mutations in the polymerase gene (rtV173L + rtL180M + rtM204V), also generating the G145R mutation in S-HBsAg due to overlapping reading frames, was stable.


  Entecavir resistance in a patient with treatment-naive HBV: A case report.
 PMID: 33903819       2021       Molecular and clinical oncology
Introduction: In fact, resistance to ETV appears to occur through a two-hit mechanism with primary LVD resistance (LVDr) substitutions (M204V/I with/without rtL180M) followed by amino acid substitutions at the rtI169, rtT184, rtS202 or rtM250 sites.


  Global prevalence and phylogeny of hepatitis B virus (HBV) drug and vaccine resistance mutations.
 PMID: 33893696       2021       Journal of viral hepatitis
Result: L180M and M204I/V were both present in all genotypes and continents that we analysed (Figure 1B, C).
Result: However, four sequences (KF214668, KF214671, KF214673 and KF214676) with RAM I269L and one sequence (KF214659) with VEM S/T143M were sampled from Asia in 1963, and one sequence (HQ700441) with RAM L180M was sampled from Oceania in 1984, demonstrating that relevant mutations can arise without exposure to treatment or vaccination.
Result: RAMs L80I/M/V, V173L, L180M, A181T/V and T184X are common to 3TC, ETV and/or TFV.


  The Occurrence of rtA194T Mutant After Long-Term Lamivudine Monotherapy Remains Sensitive to Tenofovir Disoproxil Fumarate: A Case Report.
 PMID: 33758517       2021       Infection and drug resistance
Abstract: We present here a 62-year-old CHB patient who occurred rtL180M, rtM204V and rtA194T mutants after lamivudine (LAM) monotherapy for 9 years.
Introduction: Here, we report a case of a CHB patient who developed rtM204V, rtL180M and rtA194T mutations in association with viral breakthrough on LAM monotherapy and was rescued by TDF.
Introduction: Meanwhile, phenotypic analyses revealed that constructs harboring rt


  Prevalence and characteristics of hepatitis B and D virus infections among HIV-positive individuals in Southwestern Nigeria.
 PMID: 33446224       2021       Virology journal
Abstract: HBV DRMs V173L, L180M, S202I and M204V/I, which are associated with lamivudine resistance, were detected in 32.2% (n = 10/31) of the HBV DNA-positive samples.
Discussion: Amino acid (aa) substitutions found in this study include rtL180M, rtV173L, rtM204V/I among individuals on ART however, in one drug-naive individual, aa substitutions L180M, M204V and S202I have also been detected.
Discussion: Here, we found a high prevalence of resistance mutations to nucleoside analogues and predominantly mutations usua



Browser Board

 Co-occurred Entities




   Filtrator